CIBC World Market’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$983K Buy
3,965
+601
+18% +$129K ﹤0.01% 1026
2026
Q1
$676K Buy
3,364
+235
+8% +$48.6K ﹤0.01% 1040
2025
Q4
$646K Buy
3,129
+294
+10% +$58.7K ﹤0.01% 1050
2025
Q3
$508K Buy
+2,835
New +$483K ﹤0.01% 1117
2018
Q3
Sell
-6,647
Closed -$931K 1157
2018
Q2
$931K Buy
+6,647
New +$913K ﹤0.01% 689
2017
Q3
Sell
-5,896
Closed -$672K 877
2017
Q2
$672K Buy
+5,896
New +$634K ﹤0.01% 750

Other funds holding FBT

CIBC World Market's FBT Position: Q2 2026 in Review

CIBC World Market increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 18% in Q2 2026, buying an estimated $129K and bringing the position to 3,965 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

CIBC World Market first reported a position in FBT in Q2 2017 and has held it in 6 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • CIBC World Market held 3,965 shares of First Trust NYSE Arca Biotechnology Index Fund worth $983K as of Q2 2026.
  • CIBC World Market bought 601 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $129K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1026 holding.
  • CIBC World Market first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and has held it in 6 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.